跳至主要内容
临床试验/CTRI/2014/09/004947
CTRI/2014/09/004947招募中不适用

An evaluation of egg shell derived hydroxyapatite as bone graft substitute in the healing of maxillary cystic bone defects - a clinical study.

DrVivekanand Kattimani1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2009年2月3日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20
试验地点
1
主要终点
Enhanced bone healing

研究概览

简要总结

Egg shell derived hydroxyapatite showed biocompatibility , better bone healing compared to bovine derived hydroxyapatite. Raw material for Egg shell derived hydroxyapatite is available in unlimited quantity. It can be easily sterilized by autoclaving without altering its biological properties. It’s economical and showed good bone regeneration efficacy in rats and surface modified egg shell material in human maxillary defects. .

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Outcome Assessor Blinded

入排标准

年龄范围
15.00 Year(s) 至 45.00 Year(s)(—)
性别
All

入选标准

  • Patients with periapical cyst diagnosed clinically and radiologically,who required cystectomy and grafting .

排除标准

  • Medically compromised patients.
  • Patients with metabolic diseases e.g.diabetes.

结局指标

主要结局

Enhanced bone healing

时间窗: 4-8 weeks

次要结局

  • Good bone density, early bone formation, less pain. No infection(4-8 weeks)

研究者

发起方
DrVivekanand Kattimani
申办方类型
Other [investigator initiated ]

研究点 (1)

Loading locations...

相似试验